Valuation Collegium Pharmaceutical, Inc.

Stocks

Market Closed - Nasdaq 08:00:00 03/11/26 am AEDT			5-day change	1st Jan Change
23.68 ^USD	-0.50%		+2.02%	-48.86%

29/10	Collegium Pharmaceutical, Inc. And Boston Legacy FC Expand Partnership To Support Neurodivergent Children And Families Across Massachusetts	CI
20/10	Collegium Pharmaceutical Settles Nucynta Patent Litigation for $17 Million	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	650	778.9	1,004	924	1,464	770.9	-	-
Change	-	19.82%	28.87%	-7.95%	58.4%	-47.33%	-	-
Enterprise Value (EV)	650	778.9	1,004	924	1,464	770.9	770.9	770.9
Change	-	19.82%	28.87%	-7.95%	58.4%	-47.33%	0%	0%
P/E	10x	-31.4x	23.9x	15.4x	26.8x	21.2x	6.63x	4.82x
PBR	-	-	-	-	-	-	-	-
PEG	-	0x	-0x	0.3x	-3.83x	-0.6x	0x	0.1x
Capitalization / Revenue	2.35x	1.68x	1.77x	1.46x	1.88x	0.93x	0.91x	0.91x
EV / Revenue	0x	0x	0x	0x	0x	0.93x	0.91x	0.91x
EV / EBITDA	0x	0x	0x	0x	0x	1.72x	1.86x	2.06x
EV / EBIT	0x	0x	0x	0x	0x	1.72x	1.92x	2.05x
EV / FCF	-	-	0x	0x	0x	2.74x	2.15x	1.95x
FCF Yield	-	-	27.3%	22%	22.4%	36.5%	46.5%	51.2%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	1.86	-0.74	1.29	1.86	1.73	1.117	3.573	4.915
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	276.9	463.9	566.8	631.4	780.6	833.1	844.5	849.1
EBITDA ¹	118.3	266	367	401.2	460.5	447.9	413.7	375.1
EBIT ¹	17.63	33.32	167	169.9	179.6	448.9	402.1	376.5
Net income ¹	71.52	-25	48.16	69.19	62.87	28.73	83.33	152.7
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	18.68	23.20	30.78	28.65	46.30	23.68	23.68	23.68
Nbr of stocks (in thousands)	34,797	33,572	32,611	32,250	31,611	32,556	-	-
Announcement Date	24/2/22	23/2/23	22/2/24	27/2/25	26/2/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
COLLEGIUM PHARMACEUTICAL, INC.	21.21x	-	-	-	771M
ELI LILLY AND COMPANY	41.24x	13.98x	31x	0.48%	1,257B
JOHNSON & JOHNSON	39.6x	6.65x	18.71x	1.97%	651B
ABBVIE INC.	36.2x	8.44x	17.42x	2.4%	510B
ROCHE HOLDING AG	21.41x	5.2x	12.95x	2.52%	388B
MERCK & CO., INC.	98.19x	6.02x	25.62x	2.29%	366B
NOVARTIS AG	22.92x	5.89x	14.21x	2.72%	303B
ASTRAZENECA PLC	24.43x	4.89x	13.76x	1.79%	288B
AMGEN INC.	29.52x	7.52x	13.46x	2.17%	252B
GILEAD SCIENCES, INC.	-40.78x	7.43x	46.67x	1.94%	211B
Average	29.40x	7.34x	21.53x	2.03%	422.74B
Weighted average by Cap.	36.23x	8.78x	22.70x	1.71%